HY-P2468-1mg
|
MedChemexpress LLC
|
BAD (103-127) (human) [CAS 331762-68-6]
|
|
Cancer-programmed cell death
|
|
HY-P2468-10mg
|
MedChemexpress LLC
|
BAD (103-127) (human) [CAS 331762-68-6]
|
|
Cancer-programmed cell death
|
|
HY-P2468-5mg
|
MedChemexpress LLC
|
BAD (103-127) (human) [CAS 331762-68-6]
|
|
Cancer-programmed cell death
|
|
HY-100554-10mg
|
MedChemexpress LLC
|
BMY 7378 [CAS 21102-95-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-103387-1mg
|
MedChemexpress LLC
|
DuP-697 [CAS 88149-94-4]
|
|
COVID-19-immunoregulation
|
|
HY-103387-10mg
|
MedChemexpress LLC
|
DuP-697 [CAS 88149-94-4]
|
|
COVID-19-immunoregulation
|
|
HY-103387-5mg
|
MedChemexpress LLC
|
DuP-697 [CAS 88149-94-4]
|
|
COVID-19-immunoregulation
|
|
HY-124618A-1mg
|
MedChemexpress LLC
|
FGI-106 (tetrahydrochloride) [CAS 1149348-10-6]
|
|
COVID-19-anti-virus
|
|
HY-124618A-10mg
|
MedChemexpress LLC
|
FGI-106 (tetrahydrochloride) [CAS 1149348-10-6]
|
|
COVID-19-anti-virus
|
|
HY-124618A-100mg
|
MedChemexpress LLC
|
FGI-106 (tetrahydrochloride) [CAS 1149348-10-6]
|
|
COVID-19-anti-virus
|
|
HY-124618A-5mg
|
MedChemexpress LLC
|
FGI-106 (tetrahydrochloride) [CAS 1149348-10-6]
|
|
COVID-19-anti-virus
|
|
HY-124618A-50mg
|
MedChemexpress LLC
|
FGI-106 (tetrahydrochloride) [CAS 1149348-10-6]
|
|
COVID-19-anti-virus
|
|
HY-124618A-1mL
|
MedChemexpress LLC
|
FGI-106 (tetrahydrochloride) [CAS 1149348-10-6] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
HY-W088089-100mg
|
MedChemexpress LLC
|
ICG-carboxylic acid [CAS 181934-09-8]
|
|
|
|
HY-W088089-25mg
|
MedChemexpress LLC
|
ICG-carboxylic acid [CAS 181934-09-8]
|
|
|
|
HY-W088089-50mg
|
MedChemexpress LLC
|
ICG-carboxylic acid [CAS 181934-09-8]
|
|
|
|
HY-17514-100mg
|
MedChemexpress LLC
|
Itraconazole [CAS 84625-61-6]
|
|
COVID-19-immunoregulation
|
|
HY-17514-500mg
|
MedChemexpress LLC
|
Itraconazole [CAS 84625-61-6]
|
|
COVID-19-immunoregulation
|
|
HY-17514S-1mg
|
MedChemexpress LLC
|
Itraconazole-d5 [CAS 1217510-38-7]
|
|
COVID-19-immunoregulation
|
|
HY-17514S2-1mg
|
MedChemexpress LLC
|
Itraconazole-d9 [CAS 1309272-50-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-10209A-10mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
HY-10209A-100mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
HY-10209A-200mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
HY-10209A-5mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
HY-10209A-50mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|